- Home
- DAC vs BCRX Comparison
DAC vs BCRX Comparison
Compare DAC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAC | BCRX |
|---|---|---|
| Founded | 1972 | 1986 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2006 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DAC | BCRX |
|---|---|---|
| Price | $114.40 | $8.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $105.00 | $20.82 |
| AVG Volume (30 Days) | 72.7K | ★ 3.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.16 |
| P/E Ratio | ★ $4.01 | $7.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $65.40 | $6.00 |
| 52 Week High | $118.83 | $11.31 |
Technical Indicators
Market Signals| Indicator | DAC | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 66.22 | 76.61 |
| Support Level | $91.64 | $7.95 |
| Resistance Level | N/A | $9.18 |
| Average True Range (ATR) | 2.93 | 0.34 |
| MACD | 0.75 | 0.21 |
| Stochastic Oscillator | 72.33 | 92.71 |
Price Performance
Historical ComparisonAbout DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.